Eg5 kinesin-related motor protein inhibitor ARQ 621
Term · Oncology and biomedicine · MLC-T-ONC-013233
A small-molecule inhibitor of the kinesin-related motor protein Eg5 with potential antineoplastic activity. Eg5 kinesin-related motor protein inhibitor ARQ 621 selectively inhibits the activity of Eg5, which may result in mitotic disruption, apoptosis and cell death. The ATP-dependent Eg5 kinesin-related motor protein (also known as KIF11 or kinesin spindle protein-5) is a plus-end directed kinesin motor protein involved in the regulation of spindle dynamics, including assembly and maintenance, during mitosis.
| Identifier | MLC-T-ONC-013233 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Eg5 inhibitor ARQ 621 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013233",
"term": "Eg5 kinesin-related motor protein inhibitor ARQ 621",
"field": "Oncology and biomedicine",
"definition": "A small-molecule inhibitor of the kinesin-related motor protein Eg5 with potential antineoplastic activity. Eg5 kinesin-related motor protein inhibitor ARQ 621 selectively inhibits the activity of Eg5, which may result in mitotic disruption, apoptosis and cell death. The ATP-dependent Eg5 kinesin-related motor protein (also known as KIF11 or kinesin spindle protein-5) is a plus-end directed kinesin motor protein involved in the regulation of spindle dynamics, including assembly and maintenance, during mitosis.",
"synonyms": [
"Eg5 inhibitor ARQ 621"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/eg5-kinesin-related-motor-protein-inhibitor-arq-621/"
}
Record 6,418 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.